Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.

Literature DB >> 18566316

Development of appropriate coronary heart disease risk prediction models in HIV-infected patients.

Morris Schambelan, Peter W F Wilson, Kevin E Yarasheski, W Todd Cade, Victor G Dávila-Román, Ralph B D'Agostino, Tarek A Helmy, Matthew Law, Kristin E Mondy, Sharon Nachman, Linda R Peterson, Signe W Worm.

Abstract

Entities: Disease Species

Mesh：

Year: 2008 PMID： 18566316 PMCID： PMC2648861 DOI： 10.1161/CIRCULATIONAHA.107.189627

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

51 in total

1. How bad is HAART for the HEART?

Authors: Peter Reiss
Journal: AIDS Date: 2003-11-21 Impact factor: 4.177

Review 2. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.

Authors: Naveed Sattar; David W McCarey; Hilary Capell; Iain B McInnes
Journal: Circulation Date: 2003-12-16 Impact factor: 29.690

3. Protease inhibitors and cardiovascular outcomes in patients with HIV-1.

Authors: Scott D Holmberg; Anne C Moorman; John M Williamson; Tony C Tong; Douglas J Ward; Kathy C Wood; Alan E Greenberg; Robert S Janssen
Journal: Lancet Date: 2002-11-30 Impact factor: 79.321

4. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors: Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245

5. A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study.

Authors: Troels F Thomsen; Dan McGee; Michael Davidsen; Torben Jørgensen
Journal: Int J Epidemiol Date: 2002-08 Impact factor: 7.196

Review 6. Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era.

Authors: Daniel Vittecoq; Lelia Escaut; Gilles Chironi; Elina Teicher; Jean Jacques Monsuez; Michel Andrejak; Alain Simon
Journal: AIDS Date: 2003-04 Impact factor: 4.177

7. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Authors: Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa El-Sadr; Stephan De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
Journal: AIDS Date: 2003-05-23 Impact factor: 4.177

8. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

Authors: Murielle Mary-Krause; Laurent Cotte; Anne Simon; Maria Partisani; Dominique Costagliola
Journal: AIDS Date: 2003-11-21 Impact factor: 4.177

9. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution.

Authors: Colleen Hadigan; James B Meigs; Peter W F Wilson; Ralph B D'Agostino; Benjamin Davis; Nesli Basgoz; Paul E Sax; Steven Grinspoon
Journal: Clin Infect Dis Date: 2003-03-20 Impact factor: 9.079

10. Combination antiretroviral therapy and the risk of myocardial infarction.

Authors: Nina Friis-Møller; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Peter Reiss; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Matthew G Law; Ole Kirk; Andrew N Phillips; Jens D Lundgren
Journal: N Engl J Med Date: 2003-11-20 Impact factor: 91.245

16 in total

Review 1. Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010.

Authors: James D Neaton; Jacqueline Neuhaus; Sean Emery
Journal: Curr Opin HIV AIDS Date: 2010-11 Impact factor: 4.283

Review 2. Antiretroviral treatment interruptions and risk of non-opportunistic diseases.

Authors: Kenneth A Lichtenstein
Journal: Curr HIV/AIDS Rep Date: 2009-05 Impact factor: 5.071

3. Older HIV-infected adults. Complex patients (III): Polypharmacy.

Authors: Samuel F Freedman; Carrie Johnston; John J Faragon; Eugenia L Siegler; Tessa Del Carmen
Journal: Eur Geriatr Med Date: 2018-12-06 Impact factor: 1.710

4. Lipoprotein-associated phospholipase A2, a novel cardiovascular inflammatory marker, in HIV-infected patients.

Authors: Alexandra Mangili; Raabia Ahmad; Robert L Wolfert; Jeffrey Kuvin; Joseph F Polak; Richard H Karas; Christine A Wanke
Journal: Clin Infect Dis Date: 2013-12-11 Impact factor: 9.079

5. CHA2DS2-VASc Score, Warfarin Use, and Risk for Thromboembolic Events Among HIV-Infected Persons With Atrial Fibrillation.

Authors: Katherine Hsin-Yu Chau; Rebecca Scherzer; Carl Grunfeld; Priscilla Ying Hsue; Michael G Shlipak
Journal: J Acquir Immune Defic Syndr Date: 2017-09-01 Impact factor: 3.731

9. Accelerated atherosclerosis in a human immunodeficiency virus infected patient not on highly active anti-retroviral therapy: An autopsy case report.

Authors: R Kalyani; M J Thej; K Prabhakar; J Kiran
Journal: J Cardiovasc Dis Res Date: 2011-10

10. Population-based study of risk factors for coronary heart disease among HIV-infected persons.

Authors: John Y Oh; Kari Greene; Haiou He; Sean Schafer; Katrina Hedberg
Journal: Open AIDS J Date: 2012-09-07